Bird flu could become a human pandemic. How are countries preparing?
Countries are preparing for potential bird flu pandemic by enhancing surveillance, purchasing vaccines, and developing new ones. Efforts include risk assessments, mRNA vaccine development, and global vaccine distribution.
Read original articleCountries are preparing for the potential of bird flu evolving into a human pandemic by ramping up surveillance, purchasing vaccines, and developing new ones. The highly pathogenic avian influenza H5N1 has been detected in cattle herds and farm workers in the United States, raising concerns about its potential to spread to humans. Efforts include risk assessments, outbreak predictions, and vaccine development using mRNA technology for quicker production. The World Health Organization is reviewing candidate vaccines, while countries like the US and Finland have started vaccinating high-risk individuals. Surveillance efforts involve tracking the virus's spread through increased testing in both animals and humans. Researchers are also monitoring genetic changes in the virus that could enhance its ability to infect humans. Efforts are being made to ensure an equitable global response, with a focus on vaccine distribution to low- and middle-income countries. Additionally, there are investigations into vaccinating cattle to reduce transmission, although challenges remain in developing effective vaccines for livestock.
Related
Covid Safety Measures Could Return If a Bird Flu Pandemic Is Declared
An ongoing bird flu outbreak in U.S. dairy cows led to three human cases. Safety measures like masks and vaccines are crucial. CDC monitors H5N1 exposure, highlighting the high death rate. Vaccine availability and communication are key.
New Covid Shots Recommended for Americans 6 Months and Older This Fall
The CDC urges all Americans 6 months and older to get new Covid-19 vaccines this fall. Data shows unvaccinated individuals faced severe outcomes. Vaccination is crucial to curb virus spread and protect vulnerable populations.
Combined Covid-flu vaccines are coming: Moderna jab clears major test
Moderna completes phase-III trials for a COVID-flu mRNA vaccine, showing higher efficacy in adults over 50. Plans for FDA approval highlight benefits of combination vaccines and mRNA technology's adaptability to variants.
US to pay Moderna $176M to develop pandemic flu vaccine
The U.S. government partners with Moderna for a $176 million deal to fast-track an mRNA bird flu vaccine for dairy cows. BARDA oversees the project, aiming for late-stage trials next year.
Global health leader critiques ineptitude of U.S. response to bird flu outbreak
Global health leader Seth Berkley criticized the U.S. response to the bird flu outbreak, emphasizing the lack of surveillance, tracking, and vaccine readiness. He highlighted concerns about pandemic preparedness and stressed the importance of enhancing monitoring and surveillance systems.
So many innovative indoor air quality and antiviral surface coating products have been memory holed.
Companies and government are rolling back work from home and hybrid arrangements. Coming to the office sick isn’t as taboo as it was a few years ago.
On the civil preparedness front, have we made any progress? It doesn’t seem so.
As a society, we need to be more of a learning organization. Why go through all that pain if we don’t come out better for it?
Related
Covid Safety Measures Could Return If a Bird Flu Pandemic Is Declared
An ongoing bird flu outbreak in U.S. dairy cows led to three human cases. Safety measures like masks and vaccines are crucial. CDC monitors H5N1 exposure, highlighting the high death rate. Vaccine availability and communication are key.
New Covid Shots Recommended for Americans 6 Months and Older This Fall
The CDC urges all Americans 6 months and older to get new Covid-19 vaccines this fall. Data shows unvaccinated individuals faced severe outcomes. Vaccination is crucial to curb virus spread and protect vulnerable populations.
Combined Covid-flu vaccines are coming: Moderna jab clears major test
Moderna completes phase-III trials for a COVID-flu mRNA vaccine, showing higher efficacy in adults over 50. Plans for FDA approval highlight benefits of combination vaccines and mRNA technology's adaptability to variants.
US to pay Moderna $176M to develop pandemic flu vaccine
The U.S. government partners with Moderna for a $176 million deal to fast-track an mRNA bird flu vaccine for dairy cows. BARDA oversees the project, aiming for late-stage trials next year.
Global health leader critiques ineptitude of U.S. response to bird flu outbreak
Global health leader Seth Berkley criticized the U.S. response to the bird flu outbreak, emphasizing the lack of surveillance, tracking, and vaccine readiness. He highlighted concerns about pandemic preparedness and stressed the importance of enhancing monitoring and surveillance systems.